Articles Tagged With:
-
Unified Defense Not Always Possible in Malpractice Claim
Defense counsel must be aware of competing interests in any case. Attorneys should engage in frank discussions with the hospital and any employed staff who are named defendants. There must be a cohesive strategy. Individual staff members named in lawsuits should not be speculating on whether a staffing shortage existed, or whether a staffing shortage caused or contributed to a patient’s alleged injury.
-
Neurologists Try to Predict Cognitive Impairment Earlier
Researchers used easy memory tests among healthy participants to determine who might be more likely to need closer monitoring.
-
Sitting, Standing, and Walking: The Effect on Cardiometabolic Markers
This meta-analysis explores the effects of interrupting sitting with either light-intensity walking or standing and finds that light-intensity walking is associated with the most significant impact on several markers of cardiometabolic health.
-
More Steps Mean Better Cardiovascular Health for Older Americans
In a meta-analysis, researchers found walking 6,000 to 9,000 steps daily lowered the risk of cardiovascular disease by 40% to 50% vs. walking 2,000 steps daily.
-
Limiting Meal Size and Caloric Intake May Be More Beneficial Than Time-Restricted Eating
Researchers found monitoring total caloric intake may be more effective for losing weight than intermittent fasting.
-
New Tools Can Help Healthcare Industry Cut Carbon Emissions
Leaders can take advantage of loans, grants, and tax credits available through the Inflation Reduction Act.
-
Adjunctive Corticosteroids in Patients with Severe Community-Acquired Pneumonia
A double-blind, randomized, controlled trial conducted at 31 French medical centers demonstrated adult patients with severe community-acquired pneumonia who were given hydrocortisone had a lower risk of death by day 28 compared with those who received placebo.
-
Shortening the Duration of Tuberculosis Treatment
In patients with rifampin-susceptible tuberculosis, a planned eight-week regimen of bedaquiline plus linezolid together with isoniazid, ethambutol, and pyrazinamide, combined with a careful follow-on strategy, was non-inferior to a standard six-month regimen.
-
SER-109 Improves Quality of Life Compared to Placebo in Patients with Recurrent Clostridioides difficile Infection
A secondary analysis of a Phase III clinical trial found SER-109 improved health-related quality of life for patients with recurrent C. difficile infection compared to placebo through eight weeks.
-
Challenges in Diagnosing MIS-C
Even though there are clear diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C), the initial diagnosis is not always certain, and there can be overlapping concurrent bacterial, viral, and parasitic infections that also require prompt treatment.